Phoenix Wealth Advisors Veracyte, Inc. Transaction History

Phoenix Wealth Advisors

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 23, 2021	SELL	$32.94 - $56.62 $218,721 - $375,956	-6,640 Closed	0 $0
Q1 2021 Apr 12, 2021	SELL	$44.47 - $81.38 $178,902 - $327,391	-4,023 Reduced 37.73%	6,640 $350,000
Q4 2020 Feb 05, 2021	BUY	$32.49 - $61.88 $346,440 - $659,826	10,663 New	10,663 $522,000

259

81.7M

43K

82K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $1.54B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Phoenix Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Phoenix Wealth Advisors with notifications on news.